Claude Allary
Director/Board Member at ARCH BIOPARTNERS INC.
Net worth: 341 550 $ as of 30/03/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Richard Muruve | M | - | 41 years | |
| Stanislas Veillet | M | 58 | 18 years | |
| Jean Mariani | M | 74 | 5 years | |
| Waly Dioh | M | 55 | 18 years | |
| Richard Rossman | M | - | 14 years | |
| Daniel Muruve | M | - | 41 years | |
| Nadine Coulm | F | 61 | 9 years | |
| Andrew Bishop | M | 58 | 14 years | |
| Marc Bouillet | M | - |
Genethon
 Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | - |
| Marie-Christine Ouillade | F | - |
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | - |
| Marie-Yvonne Landel-Meunier | F | 71 |
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | - |
| Laurence Tiennot-Herment | F | - |
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | 15 years |
| Frédéric Revah | M | 62 |
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | 14 years |
| Claude Le Pen | M | - |
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | - |
| Jean-Pierre Lamorte | M | - |
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | 17 years |
| Alexandre Lemoalle | M | - |
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | 9 years |
| Pierre Dilda | M | 54 | 9 years | |
| Nathalie Triclin-Conseil | F | - |
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | - |
| Marie-Christine Belleville | F | - |
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | - |
| Nicolas Fellmann | M | 55 | 1 years | |
| Rob van Maanen | M | 54 | 3 years | |
| Chiara Baccelli | M | 48 | 1 years | |
| Edouard Bieth | M | 44 | 1 years | |
| Claudia Ferreira | F | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Philippe Rousseau | M | 53 | 1 years | |
| Evelyne Nguyen | F | 56 | 2 years | |
| Adrian Haigh | M | 64 | 7 years | |
| Jean Franchi | F | 57 | 4 years | |
| Dimitri Batsis | M | 58 | 5 years | |
| Bart Goddyn | M | - | 1 years | |
| Patrick Volkert Vink | M | 60 | 3 years | |
| Samuel Agus | M | 56 | 3 years | |
| Benoit Canolle | M | 46 | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| France | 27 | 81.82% |
| Canada | 6 | 18.18% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Claude Allary
- Personal Network
